Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: A head-to-head comparison

European Journal of Neurology

Volumn 21, Issue 6, 2014, Pages 860-866

  Hellwig, S ^a   Reinhard, M ^a   Amtage, F ^a   Guschlbauer, B ^a   Buchert, R ^b   Tuscher O ^a,c   Weiller, C ^a   Niesen, W D ^a   Meyer, P T ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Atypical parkinsonian syndrome; Parkinsonism; Positron emission tomography; Transcranial sonography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BRAIN THIRD VENTRICLE; CLINICAL ARTICLE; CORTICOBASAL DEGENERATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; ECHOENCEPHALOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MALE; PARKINSON DISEASE; PARKINSONISM; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; REAL TIME ULTRASOUND SCANNER; SENSITIVITY AND SPECIFICITY; SHY DRAGER SYNDROME; SUBSTANTIA NIGRA; TRANSCRANIAL B MODE SONOGRAPHY; ULTRASOUND TRANSDUCER; UNIFIED PARKINSON DISEASE RATING SCALE; BRAIN; DIAGNOSTIC USE; DOPPLER ECHOGRAPHY; ECHOGRAPHY; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; PARKINSONIAN DISORDERS; SCINTISCANNING; SUPRANUCLEAR PALSY, PROGRESSIVE;

AGED; BRAIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; PARKINSONIAN DISORDERS; SENSITIVITY AND SPECIFICITY; SUPRANUCLEAR PALSY, PROGRESSIVE; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 84899977467     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12394     Document Type: Article

References (21)

1. Brooks DJ. Imaging approaches to Parkinson disease. J Nucl Med 2010; 51: 596-609.
2. Eckert T, Barnes A, Dhawan V, et al. FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage 2005; 26: 912-921.
3. 123I]IBZM-SPECT for the differential diagnosis of parkinsonism. Neurology 2012; 79: 1314-1322.
4. Tang CC, Poston KL, Eckert T, et al. Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. Lancet Neurol 2010; 9: 149-158.
5. Walter U, Behnke S, Eyding J, et al. Transcranial brain parenchmyma sonography in movement disorders: state of the art. Ultrasound Med Biol 2007; 33: 15-25.
6. Vlaar AM, Bouwmans A, Mess WH, et al. Transcranial duplex in the differential diagnosis of parkinsonian syndromes: a systematic review. J Neurol 2009; 256: 530-538.
7. Litvan I, Bhatia KP, Burn DJ, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders. Mov Disord 2003; 18: 467-486.
8. Minoshima S, Koeppe RA, Mintun MA, et al. Automated detection of the intercommissural line for stereotactic localization of functional brain images. J Nucl Med 1993; 34: 322-329.
9. Stockner H, Schwingenschuh P, Djamshidian A, et al. Is transcranial sonography useful to distinguish scans without evidence of dopaminergic deficit patients from Parkinson's disease? Mov Disord 2012; 27: 1182-1185.
10. Vlaar A, Tromp SC, Weber WE, et al. The reliability of transcranial duplex scanning in parkinsonian patients: comparison of different observers and ultrasound systems. Ultraschall Med 2011; 32: 83-88.
11. Walter U, Dressler D, Probst T, et al. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease. Arch Neurol 2007; 64: 1635-1640.
12. Walter U, Dressler D, Wolters A, et al. Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy. Neurology 2004; 63: 504-509.
13. Walter U, Niehaus L, Probst T, et al. Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology 2003; 60: 74-77.
14. Gaenslen A, Unmuth B, Godau J, et al. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study. Lancet Neurol 2008; 7: 417-424.
15. Bouwmans AE, Vlaar AM, Mess WH, et al. Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson's disease: prospective cohort study in 196 patients. BMJ Open 2013; 3: e002613.
16. Behnke S, Berg D, Naumann M, et al. Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound. J Neurol Neurosurg Psychiatry 2005; 76: 423-425.
17. Bouwmans AE, Vlaar AM, Srulijes K, et al. Transcranial sonography for the discrimination of idiopathic Parkinson's disease from the atypical parkinsonian syndromes. Int Rev Neurobiol 2010; 90: 121-146.
18. Ling H, O'Sullivan SS, Holton JL, et al. Does corticobasal degeneration exist? A clinicopathological re-evaluation Brain 2010; 133: 2045-2057.
19. Becker G, Berg D. Neuroimaging in basal ganglia disorders: perspectives for transcranial ultrasound. Mov Disord 2001; 16: 23-32.
20. Burdette JH, Minoshima S, Vander Borght T, et al. Alzheimer disease: improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections. Radiology 1996; 198: 837-843.
21. Herholz K, Salmon E, Perani D, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 2002; 17: 302-316.